Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication.

[1]  G. Currie.  Activated macrophages kill tumour cells by releasing arginase , 1978, Nature.

[2]  M. Marletta,et al.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. , 1988, Biochemistry.

[3]  B. Meldrum,et al.  Ischaemic brain damage: the role of excitatory activity and of calcium entry. , 1985, British journal of anaesthesia.

[4]  S. Moncada,et al.  A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[5]  J. Hibbs,et al.  Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.

[6]  T. Deguchi,et al.  Blockade by N-methylhydroxylamine of activation of guanylate cyclase and elevations of guanosine 3',5'-monophosphate levels in nervous tissues. , 1978, Biochimica et biophysica acta.

[7]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[8]  R. Busse,et al.  Differential role of extra‐ and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells , 1988, British journal of pharmacology.

[9]  R. Furchgott.  The role of endothelium in the responses of vascular smooth muscle to drugs. , 1984, Annual review of pharmacology and toxicology.

[10]  P. Vanhoutte,et al.  Endothelium-derived relaxing factor inhibits renin release. , 1988, European journal of pharmacology.

[11]  S Moncada,et al.  Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Moncada,et al.  A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation , 1989, British journal of pharmacology.

[13]  J. Perfect,et al.  Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. , 1988, The Journal of clinical investigation.

[14]  T. Deguchi,et al.  L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. , 1982, The Journal of biological chemistry.

[15]  D. Stuehr,et al.  An L-arginine-dependent mechanism mediates kupffer cell inhibition of hepatocyte protein synthesis in vitro , 1989, The Journal of experimental medicine.

[16]  M. Caldwell,et al.  Arginine metabolism in wounds. , 1988, The American journal of physiology.

[17]  B. Appelgren,et al.  Vasopressin release in response to intracerebroventricular L-alanine and L-arginine, and its dependence upon CSF NaCl concentration. , 1982, Acta physiologica Scandinavica.

[18]  P. Kamoun,et al.  Superoxide‐induced deimination of arginine in hematopoietic cells , 1988, FEBS letters.

[19]  J. Beck,et al.  Alimentary factors in the endocrine response to administration of arginine in man. , 1968, Lancet.

[20]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[21]  S. Moncada,et al.  Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. , 1988, Biochemical pharmacology.

[22]  J. Shiloah,et al.  Blood nitrates and infantile methemoglobinemia. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[23]  A. Barbul.  Arginine: biochemistry, physiology, and therapeutic implications. , 1986, JPEN. Journal of parenteral and enteral nutrition.

[24]  T. Deguchi.  Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain. , 1977, The Journal of biological chemistry.

[25]  T. Merimee,et al.  Effect of arginine on serum-levels of human growth-hormone. , 1965, Lancet.

[26]  H. Schmidt,et al.  Arginine is a physiological precursor of endothelium-derived nitric oxide. , 1988, European journal of pharmacology.

[27]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  V. Miller,et al.  Endothelium-dependent responses in isolated blood vessels of lower vertebrates. , 1986, Blood vessels.

[29]  C. Nathan,et al.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.

[30]  D. Choi.  Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage , 1988, Trends in Neurosciences.

[31]  S. G. Laychock.  Mediation of insulin release by cGMP and cAMP in a starved animal model , 1983, Molecular and Cellular Endocrinology.

[32]  J. Schrader,et al.  Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. , 1988, Biochemical and biophysical research communications.

[33]  C. Nathan,et al.  Identification of arginine as a precursor of endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Schrader,et al.  Nitric oxide release from the isolated guinea pig heart. , 1988, European journal of pharmacology.

[35]  E. Seifter,et al.  Supplemental arginine increases thymic cellularity in normal and murine sarcoma virus-inoculated mice and increases the resistance to murine sarcoma virus tumor. , 1979, JPEN - Journal of Parenteral and Enteral Nutrition.

[36]  J. Palmer,et al.  Arginine-stimulated Acute Phase of Insulin and Glucagon Secretion: I. In Normal Man , 1975, Diabetes.

[37]  P. Goldman,et al.  Nitrate synthesis in the germfree and conventional rat. , 1981, Science.

[38]  M. Koulu,et al.  Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus. , 1988, European journal of pharmacology.

[39]  M. Lewis,et al.  In vivo EDRF activity influences platelet function , 1988, British journal of pharmacology.

[40]  S. Moncada,et al.  The Discovery of Nitric Oxide as the Endogenous Nitrovasodilator , 1988, Hypertension.

[41]  A. Abdelal.  Arginine catabolism by microorganisms. , 1979, Annual review of microbiology.

[42]  J. Hibbs,et al.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.

[43]  T. Rimele,et al.  Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. , 1988, The Journal of pharmacology and experimental therapeutics.

[44]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[45]  R. Furchgott,et al.  Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[46]  S. Moncada,et al.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. , 1988, Biochemical and biophysical research communications.

[47]  D. Kritchevsky,et al.  Atherogenicity of animal and vegetable protein. Influence of the lysine to arginine ratio. , 1982, Atherosclerosis.

[48]  P. Ramwell,et al.  Vasodilatory properties of mono-L-arginine-containing compounds. , 1988, Biochemical and biophysical research communications.

[49]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[50]  E. Seifter,et al.  Citrulline does not share the thymotropic properties of arginine and ornithine. Abstr. , 1979 .

[51]  K. Kuriyama,et al.  Activation of cerebral guanylate cyclase by nitric oxide. , 1977, Biochemical and biophysical research communications.

[52]  S. Tannenbaum,et al.  Mammalian nitrate biosynthesis: incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Weir,et al.  Somatostatin and Pancreatic Polypeptide Secretion: Effects of Glucagon, Insulin, and Arginine , 1978, Diabetes.

[54]  S. Moncada,et al.  Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator , 1988, British journal of pharmacology.

[55]  Imms Fj,et al.  The secretion of catecholamines from the adrenal gland following arginine infusion in the rat. , 1969 .

[56]  J. Hibbs,et al.  The L‐Arginine Dependent Effector Mechanism Is Induced in Murine Adenocarcinoma Cells by Culture Supernatant From Cytotoxic Activated Macrophages , 1988, Journal of leukocyte biology.

[57]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[58]  S. Yen,et al.  Prolactin and growth hormone release in response to sequential stimulation by arginine and synthetic TRF. , 1973, The Journal of clinical endocrinology and metabolism.

[59]  A. Mulloy,et al.  Dietary Arginine, Insulin Secretion, Glucose Tolerance and Liver Lipids during Repletion of Protein-Depleted Rats , 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[60]  C. Nathan,et al.  Activated Murine Macrophages Secrete a Metabolite of Arginine with the Bioactivity of Endothelium-derived Relaxing Factor and the Chemical Reactivity of Nitric Oxide Materials and Methods , 2022 .